capsensixx AG

  • WKN: A2G9M1
  • ISIN: DE000A2G9M17
  • Land: Deutschland

Nachricht vom 20.06.2018 | 14:38

capsensixx AG: Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

capsensixx AG / Home Member State

20.06.2018 / 14:38
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


capsensixx AG announces according to Art. 5 WpHG that Germany is the Home Member State.
20.06.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: capsensixx AG Bettinastraße 57-59 60325 Frankfurt Germany Internet: www.capsensixx.de End of News DGAP News Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Fresenius Medical Care AG & Co. KGaA passt Besetzung des Vorstands an neues Betriebsmodell an

01. Dezember 2021, 08:30

Aktueller Webcast

HelloFresh SE

Capital Markets Day

08. Dezember 2021

Aktuelle Research-Studie

Li-Metal Corp.

Original-Research: Li-Metal Corp. (von Sphene Capital GmbH): Buy

01. Dezember 2021